CLINICAL_TRIALS
research
· 2026-01-09
Clinical Trial Update: Trial of Aldosterone-hybrid SteRoid for Guiding curablE Treatment of Primary Aldosteronism (TARGET-PA) [NA]
Summary
This entry describes the TARGET-PA trial evaluating an aldosterone-hybrid steroid to guide curable treatment of primary aldosteronism; the study status is not y…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Changi General Hospital | Conditions: Hyperaldosteronism; Primary, Primary Aldosteronism Due to Aldosterone Producing Adenoma | NA | Status: NOT_YET_RECRUITING